Literature DB >> 8709703

APOE genotyping in differential diagnosis of Alzheimer's disease.

A J Slooter, M B Breteler, A Ott, C Van Broeckhoven, C M van Duijn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8709703     DOI： 10.1016/s0140-6736(05)64501-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Familial risk for Alzheimer's disease alters fMRI activation patterns.

Authors:  Susan Spear Bassett; David M Yousem; Catherine Cristinzio; Ivana Kusevic; Michael A Yassa; Brian S Caffo; Scott L Zeger
Journal:  Brain       Date:  2006-05       Impact factor: 13.501

2.  Clinical overdiagnosis of vascular dementia versus necropsy confirmed series.

Authors:  A D Roses; A M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

3.  Prediction of cognitive decline in healthy older adults using fMRI.

Authors:  John L Woodard; Michael Seidenberg; Kristy A Nielson; J Carson Smith; Piero Antuono; Sally Durgerian; Leslie Guidotti; Qi Zhang; Alissa Butts; Nathan Hantke; Melissa Lancaster; Stephen M Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

Review 5.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 6.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.